COVID Will be ‘Ongoing Battle’ for Next Few Years, says President of Vaccine Maker Moderna

COVID Will be ‘Ongoing Battle’ for Next Few Years, says President of Vaccine Maker Moderna

The fight against COVID-19 could be an “ongoing battle for the next couple of years,” the president of Moderna has said.

The pharmaceutical company this week revealed that its existing COVID-19 vaccine, mRNA-1273, which was approved for use in the U.S. by the Food and Drug Administration (FDA) last month, could offer protection against two new fast-spreading variants of the virus, the B.1.1.7 strain and the B.1.351 strain.

However, Moderna also warned that as long as the virus continues to spread between people, it will continue to mutate, which will lead to further new strains emerging.

“The virus is going to evolve as long as it’s infecting,” the president of Moderna, Dr. Stephen Hoge, said during a conference call on Monday.